| "The 4-year course in eight semesters was conducted on Public-Private-Partnership (PPP) basis under the umbrella of Jadavpur University and its Department of Pharmaceutical Technology," Subir Pal, CEO and president, Bengal Institute of Pharmaceutical Sciences, told Business Standard. |
| The 13,500 sq ft institute on a 33-acre plot of West Bengal government's State Pharmacopoeial Laboratory & Pharmacy for Indian Medicine premises at Kalyani, Nadia also had a 15-acre medicinal plant garden, 5 bigha medicinal plant nursery, 20,000 sq ft ayurvedic medicine manufacturing factory and an Ayurvedic medicine testing house. |
| "This is the second pharmaceutical institute in India, first being in Jamnagar, Gujarat," added Pal. |
| "Since Jadavpur University faculty teach our students here, a part of the fees goes to them too," said Pal. |
| The global herbal market, estimated at $162 billion annually (2002-03) is expected to expand by $3 trillion (3x1012) by the year 2020 and $5 trillion by 2050 as prescribed by the World Health Organisation (WHO). |
| "Automatically, there would be a phenomenal demand for pharmaceutical sciences professionals," said C. M Ghosh, Director of State Pharmacopoeial Laboratory and Pharmacy for Indian Medicines, Kalyani, West Bengal. |
| According to a World Health Organisation (WHO) report, after Information Technology (IT), the next boom is for the pharmaceutical and construction industry. |
| "The boom is justified because if one molecule of a synthetically-made medicine would cost Rs 4,000 crore, a new molecule isolation through Plant Made Pharmaceuticals (PMP) would cost Rs 500 crore," Ghosh said. |
| The plant made pharmaceuticals (PMP) market was growing at 20 per cent every year. |
| In India, more than 70 per cent of the patients are still treated with plant-based medicine, claimed Ghosh. |
| India can export both the herbs and its products sharing the approximate global market of $3 trillion in 2020. |
| West Bengal has 300 odd manufacturers of Ayurvedic and Yunani medicines. India contributed 0.8 per cent to the world market of plant-medicinal products with 7,500-odd ayurvedic manufacturing units. |
| "If 2 people are employed per manufacturing unit, the demand is immediately that of 15,000 professionals," added Ghosh. |
| "As per Drugs & Cosmetic Rule 1945 of government of India, B Pharm (Ayur) degree is an essential qualification for Techno-Managerial jobs of Ayurvedic/Herbal industries. Graduates can also become manufacturing chemists or take up ayurvedic-medicine-quality-control jobs. Students can also bag industrial jobs," said Pal. |
| Ayurveda graduates would have to work with Ayurvedic drug manufacturing industries and GMP standards to be employable. |
| "The fact that India, by virtue of its low cost technical manpower, is likely to emerge as a global R & D hub, further boots the employment opportunities. Moreover, Ayurveda is an area that offers the maximum possibilities for patent filings," said Ghosh. |
| At present, there were 30 students. |
| Any Science student with minimum 50 per cent aggregate was eligible through the West Bengal Joint Entrance Examination (WBJEE). |
Top Section
Explore Business Standard